A healthtech sales model is a go-to-market approach for companies selling into healthcare providers and payers, built around the fact that a security review, an EHR integration assessment, and a clinical pilot sit inside the sales funnel as real stages, not steps that happen after a deal closes. A generic B2B SaaS motion assumes a champion can sign, provision, and expand on their own timeline. In a hospital or health plan, that champion is one voice in a committee spanning IT, security, compliance, finance, supply chain, and often a clinical leader with final say on anything touching patient care.

That structure is what makes healthtech sales slow in ways that look like dysfunction from the outside and ordinary risk management from the inside. A CIO who blocks a deal over a data flow diagram isn't stalling, she's doing her job. A pilot running four months with no defined conversion path isn't patience, it's a deal with no next step. Vendors who treat these as friction to route around lose to ones who build them into the plan from the first call.

This growth framework covers the buying committee, the security gate, EHR integration reality, structuring a pilot that converts, GPOs and IDNs, budget calendars, the value case, and where the payer motion diverges from the provider motion, plus the failure modes that quietly kill deals that looked healthy.

Key Facts: HealthTech Sales Model

Epic holds 43.7% of US acute care hospitals and 56.9% of hospital beds (Safeguard Consulting Group, June 2026), and KLAS records Oracle Health in a third consecutive year of declining market share and customer satisfaction, with EHR purchase decisions down 40% against 2024. (KLAS, US Acute Care EHR Market Share 2026)

A Rock Health survey found 60 to 70% of enterprise pilots converted to paying contracts, but one health plan deal still ran 18-plus months once pilot interest, sponsor identification, security assessment, and contracting were added up. (Rock Health, 2017)

About 97% of US hospitals hold an affiliation with a group purchasing organization, a channel that opens doors but rarely closes a deal on its own. (Definitive Healthcare, October 2025)

Under CMS's Interoperability and Prior Authorization Final Rule (CMS-0057-F), most affected payers must stand up Provider Access, Payer-to-Payer, and Prior Authorization APIs by January 1, 2027, a deadline still ahead. (CMS)

ASTP/ONC's HTI-5 proposal, which would loosen several certification and information-blocking requirements, remained a pending proposed rule as of this writing, its comment period closed February 27, 2026. (Federal Register, December 2025)

What Makes HealthTech Sales Structurally Different From SaaS Sales

A B2B SaaS growth framework optimizes a funnel where the user, buyer, and payer are often the same person. In a hospital, those roles almost never overlap, and a fourth party, the patient whose data and care are on the line, sits behind all of them without ever appearing in a sales call. Healthtech sales carries obligations to people who aren't in the room, and the buying committee exists partly to represent them.

The other difference is what "risk" means. A missed SaaS renewal costs a vendor revenue. A failed integration or a clinical workflow that adds documentation burden can cost a hospital a regulatory finding, a lawsuit, or a patient safety event. That asymmetry is why healthcare buyers move slowly, even when the product is objectively good.

Constraint	What it forces	How it changes the sales motion
Multiple accountable stakeholders	No single buyer can say yes alone	Every deal needs a multi-threaded complex sales model
Regulatory exposure (HIPAA, state privacy law)	A security review before real evaluation starts	Security review becomes a funnel stage with its own exit criteria
Clinical safety	Anything touching care needs clinical sign-off	Clinical validation sits between demo and contract
EHR dependency	Most workflows need to read or write patient data	IT and the EHR team gain informal veto power over scope and timeline
Fragmented procurement	GPOs, IDNs, and facilities all buy differently	The same product sells through three different paths depending on the account

Who Actually Sits on the Buying Committee

Selling into a hospital or health system means selling to a committee that rarely meets all at once and never agrees on priorities without a fight. Understanding each seat matters more here than in most enterprise sales frameworks, because one unaddressed objection can end a deal every other stakeholder wanted. The same committee shape, with a functional buyer who sponsors and a technical buyer who can veto, drives the HR tech sales framework, which is the other category where an internal system of record decides how a deal is scoped.

Role	What they care about	What kills the deal for them
Clinical leadership (CMO, CNO, service line chief)	Patient safety, clinical evidence, workflow burden	No evidence of improved care, added clicks
CIO / IT leadership	Integration feasibility, technical debt	Unclear integration path, overpromised architecture
CISO / security	Data flows, breach exposure, third-party risk	Incomplete documentation, unclear subcontractor access
Compliance / privacy officer	HIPAA, state privacy law, the BA relationship	No signed BAA, vague answers on data location
Finance / CFO's office	Total cost, ROI, budget line	A value case that doesn't survive finance's math
Supply chain / procurement	Contract terms, GPO alignment, bids	Pricing outside GPO terms, no justification
Clinical or operational champion	Solving a real problem they own	Outvoted, with no budget of their own

Building an ideal customer profile here means describing the account and its committee together. A hospital fitting on size and specialty but with no in-house CISO is a different sales motion than one with an identical need and a slow IT board.

The Security and Privacy Gate: HIPAA, HITRUST, and SOC 2 as a Funnel Stage

Treating security review as paperwork to finish after the deal is verbally agreed is the single most common reason healthtech cycles blow past forecast. A covered entity is legally required to have a signed business associate agreement (BAA) with any vendor that creates, receives, maintains, or transmits protected health information on its behalf, spelling out permitted uses, safeguards, and breach-reporting duties before real data can flow (HHS). No signed BAA, no pilot with real patient data.

Around that legal floor sits a set of trust signals buyers use to shortcut diligence. None substitute for the BAA or guarantee a sale, but missing all of them typically adds months.

Proof point	What it demonstrates	Who asks for it	When it surfaces
Signed business associate agreement	Legal basis to handle protected health information	Compliance and legal, always	Before any real patient data flows, including pilots
SOC 2 Type II report	Operating effectiveness of security controls over time	CISO, IT security	Early in review, often before a demo with real data
HITRUST CSF certification or assessment	A healthcare-specific control framework mapped to HIPAA and other standards	Larger health systems and payers, often a stated default	Mid-to-late review, sometimes an RFP requirement
Penetration test results and subcontractor disclosure	Real attack testing, plus who else touches the data (cloud host, AI vendor)	Security and privacy, together	Alongside the SOC 2 report

The trap is treating this gate as a checkbox instead of a stage with its own owner. Vendors who assign a real person to shepherd it, with a standing packet of BAA language, SOC 2 report, and architecture diagrams ready, clear this stage faster.

EHR Integration Reality: Epic, Oracle Health, and FHIR APIs

Almost every healthtech product needs to read from or write to the electronic health record, and which EHR an account runs changes the technical lift and the leverage available to a vendor. Epic holds 43.7% of US acute care hospitals and 56.9% of hospital beds (Safeguard Consulting Group, June 2026), and Oracle Health (the EHR business Oracle acquired from Cerner in 2022) sits second in a third consecutive year of declining share and customer satisfaction (KLAS, US Acute Care EHR Market Share 2026).

Integration path	What it enables	Typical added time	What it changes about the deal
Epic App Orchard / native integration	Deep workflow embedding, in-EHR launch	Weeks to months, once security review clears	Epic's approval process becomes a dependency
Oracle Health integration	Similar embedding on the Millennium platform	Comparable to Epic	Fewer smaller hospitals run it after recent share losses
Standards-based FHIR API (SMART on FHIR)	Read or write specific data, no deep custom build	Faster for read-only cases	Portable, but limited to what the API exposes
Manual or interface-engine integration (HL7 v2)	Works with older, less standardized systems	Often the longest path, especially at rural facilities	Usually needs a dedicated IT project

Federal policy keeps pushing toward standardized APIs, but the shift is gradual. TEFCA, the national framework connecting Qualified Health Information Networks, has scaled fast since going live, and information-blocking enforcement is active: ASTP/ONC began issuing nonconformity letters to certified EHR developers in February 2026. Meanwhile ASTP/ONC's own HTI-5 proposal, which would loosen several certification requirements, remained an open proposed rule as of this writing (Federal Register, December 2025). Sell the integration path that exists today, not one a proposal might create.

Pilots and Clinical Validation: Structuring a Pilot That Converts

In most software categories, a pilot means a free trial with a shortened evaluation window. In healthcare, it usually means running the product inside real workflows long enough to gather evidence a committee can act on. That's what separates a pilot built to convert from one built to stall. The pattern echoes POC and pilot programs in general SaaS, with one addition: the output has to satisfy clinical and compliance stakeholders too.

A Rock Health survey found 60 to 70% of enterprise digital health pilots converted to paying contracts, with no meaningful gap between paid and unpaid ones (Rock Health, 2017). The pilots that failed mostly shared one trait: nobody had agreed in advance on what "success" looked like.

Pilot pattern that stalls	Pilot pattern built to convert
Open-ended timeline with no end date	A fixed window (typically 60 to 120 days) agreed before it starts
Success defined loosely as "seeing how it goes"	Two or three numeric conversion criteria, agreed in writing with the economic buyer
Run entirely by the clinical champion, no finance or IT involved	Finance and IT sign off on criteria before the pilot begins, so conversion is procedural, not a re-litigation
No plan for what happens if criteria are met	A pre-negotiated path to contract, ideally with pricing agreed in advance
Measures usage or satisfaction only	Measures the outcome the value case leans on later: time saved, cost avoided, or a clinical metric that moves

A pilot without conversion criteria isn't a sales stage, it's unpaid work with an uncertain ending. Building the criteria alongside the value case, rather than after results come in, keeps both consistent and gives the champion something concrete to bring back to their committee.

Group Purchasing Organizations and Integrated Delivery Networks

Provider procurement rarely runs through one facility deciding alone. Two structures shape where the buying power sits, and getting the target wrong wastes a cycle chasing an account that can't sign.

Structure	How it works	Where it helps a vendor	Where it slows a vendor down
Group purchasing organization (GPO)	A collective negotiates pricing and terms that member facilities can access	About 97% of US hospitals hold a GPO affiliation, so access can open doors across many accounts at once (Definitive Healthcare, October 2025)	A GPO contract alone rarely closes a deal, individual facilities still decide whether to adopt
Integrated delivery network (IDN)	Hospitals, clinics, sometimes a health plan under shared governance	One system-level decision opens many facilities, similar to account-based growth at scale	System-level review applies to every facility, so the gate is slower but the reward is bigger
Independent or single-facility purchasing	The facility decides and contracts on its own	Faster cycle, fewer stakeholders	Smaller contract value, and a template that doesn't scale to the next facility

For go-to-market framework design: a GPO relationship is a door-opener, not a closer, while an IDN-level relationship is the closer, provided the vendor can survive a system-wide security review rather than a lighter, single-facility one.

Building the Value Case: Reimbursement, Staffing, and Budget

A value case that only claims the product is useful rarely survives contact with a hospital's finance office. It has to tie to a specific budget line and how the organization measures return, and healthcare gives vendors three real angles, each with a different audience and proof.

Framing angle	Who it's aimed at	What proves it	Budget it typically draws from
Reimbursement impact	CFO, revenue cycle leadership	Evidence tied to billing codes, denial rates, or payer mix	Usually operating, since it affects ongoing revenue
Staffing cost offset	COO, nursing or department leadership	Hours saved per clinician, validated during the pilot	Operating, against headcount and overtime
Throughput or capacity	Service line leaders, facilities planning	More patients seen or beds turned per period, no added staff	Either, capital asset or subscription

The capital-versus-operating distinction decides who approves the purchase and when. A capital purchase competes against every other infrastructure request the system funds that cycle, from imaging equipment to facility upgrades, tied to an annual budgeting calendar, so missing the window can mean waiting a full year. An operating expense competes against staffing and supply lines instead, without the same board-level approval, one reason many vendors price as a subscription even when a license would otherwise make sense. Selling late in a fiscal year means selling into a budget that's already committed, not one still being planned.

The Payer Motion: Where Selling to Health Plans Differs

Selling into a health plan shares the multi-stakeholder shape of selling into a provider, but the committee, economics, and regulatory backdrop differ enough to cause real mistakes when treated as the same motion.

Dimension	Provider motion	Payer motion
Core buying committee	Clinical leadership, CIO, CISO, compliance, finance	Medical director, actuarial and finance, IT and security, network operations, quality/Stars team
Primary economic lens	Cost savings, throughput, or reimbursement capture at the point of care	Medical loss ratio math: insurers must spend a fixed, regulated share of premium on medical care, which shapes whether a vendor's fee counts as medical or administrative spend
Regulatory driver adding cycle time	HIPAA, state licensure, EHR certification	CMS-0057-F: most affected payers must stand up Provider Access, Payer-to-Payer, and Prior Authorization APIs by January 1, 2027 (CMS)
Typical procurement path	GPO-anchored or IDN-level, sometimes single-facility	Formal RFP more often than not, tied to a plan year
What "value" has to prove	Clinical outcome, staff time, or capacity	Medical cost trend, Stars impact, or compliance risk reduction

The MLR constraint is the detail generic B2B advice never accounts for. A fee classified as administrative rather than medical spend can worsen a plan's own regulatory math, so the pitch sometimes has to address accounting classification before the product, a different discipline than consultative selling in most B2B categories.

Failure Modes That Quietly Kill HealthTech Deals

A handful of mistakes account for most healthtech deals that looked promising for months, then died without producing a clear "no."

Failure mode	What it looks like	The fix
Selling to a clinical champion with no budget	Real enthusiasm, no path to signature because finance was never in the room	Identify the economic buyer early, using champion-based selling as a starting map
A pilot with no conversion criteria	Months of "it's going well" with no agreed definition of done	Set numeric criteria and a pre-negotiated path to contract
Underpricing the implementation	A low price that doesn't cover integration, training, and change management	Price implementation as its own line, scoped to the integration path
Skipping security review until late	A verbal deal stalls for months once compliance asks for a BAA and SOC 2 report	Start the security packet before the first technical call
Treating a GPO contract as a closed deal	Assuming pricing access means facilities will adopt	Treat GPO access as a door-opener, then run a real motion at the facility or IDN level
Ignoring the budget calendar	Closing a verbal agreement when the relevant budget is already spent	Confirm which budget cycle a deal draws from before forecasting the close

A Stage-by-Stage Sales Sequence, Discovery Through Expansion

Compressing a healthtech cycle comes from running the slow stages in parallel and starting them earlier than instinct suggests, not from skipping any. This mirrors the discipline behind stage exit criteria in B2B revenue operations, with healthcare-specific gates layered in.

Stage	Focus	Typical duration	What unlocks the next stage
Discovery and clinical fit	Confirm the problem, identify the champion	2 to 6 weeks	A named champion and a sense of who else must say yes
Security and privacy review	BAA, SOC 2, HITRUST posture, architecture review	4 to 12 weeks, run in parallel where possible	A signed BAA and a security team that isn't objecting
IT and EHR integration scoping	Confirm the path and its cost	2 to 8 weeks	A documented plan the CIO's team has reviewed
Pilot or clinical validation	Real workflow use against pre-agreed criteria	60 to 120 days	Criteria met, finance and clinical leadership signed off
Committee decision and contracting	Sign-off across clinical, IT, security, compliance, finance, plus procurement terms	4 to 12 weeks, longer at IDN scale	A signed contract with scope and pricing settled
Implementation and go-live	Integration build, training, workflow rollout	1 to 6 months, integration-dependent	Live usage generating evidence for the next sale
Expansion	Additional departments, facilities, or the wider IDN	Ongoing	A proof point the next site's committee can act on

The stages that compress fastest are the ones a vendor starts before being asked, not the ones a buyer has to remind them about.

Conclusion

A healthtech sales model works when it treats the buying committee, the security gate, the EHR integration, and the clinical pilot as designed stages with real owners and exit criteria, not obstacles a good product can talk its way around. That doesn't argue for moving slowly out of caution. It argues for starting the slow parts early and building a value case against the economics the account actually uses to decide, whether that's reimbursement, staffing cost, throughput, or a payer's medical loss ratio math.

Companies that get this right stop treating a stalled pilot or a security review as bad luck. They build the muscle to run both on purpose, the way a strong long-cycle sales framework treats a long cycle as something to plan for.

Frequently Asked Questions about HealthTech Sales

How is a healthtech sales model different from a standard B2B SaaS sales motion?

A standard SaaS motion assumes the user, buyer, and payer are roughly the same person, and a champion can move a deal on their own timeline. A healthtech sales model adds a security review, an EHR integration assessment, and often a clinical pilot as real funnel stages, decided by a committee spanning clinical leadership, IT, security, and finance.

What does the HIPAA business associate agreement actually require, and when does a vendor need one?

A covered entity must have a signed business associate agreement with any vendor that creates, receives, maintains, or transmits protected health information on its behalf, defining permitted uses, safeguards, and breach-reporting duties. No signed BAA means no real patient data can flow, so security review has to start before a pilot, not after a verbal agreement.

Does a vendor need HITRUST certification to sell into hospitals?

Not always, but larger health systems and payers increasingly ask for a HITRUST CSF assessment or a SOC 2 Type II report during security review, sometimes as a stated RFP requirement. Neither replaces the BAA or guarantees a sale, but missing both adds real time to that stage.

How should a healthcare pilot be structured so it actually converts to a contract?

Agree on a fixed timeline, usually 60 to 120 days, and two or three numeric success criteria in writing before it starts, with finance and IT signed off alongside the champion. A Rock Health survey found 60 to 70% of enterprise digital health pilots converted when structured this way, but pilots with no agreed definition of success stall indefinitely.

What's the difference between selling to a hospital and selling to a health plan?

A hospital's economics center on cost savings, throughput, or reimbursement capture at the point of care, while a health plan weighs whether a fee counts as medical or administrative spend under its medical loss ratio. Payers also run more formal RFPs and face their own interoperability mandates, like the CMS rule requiring new APIs by January 1, 2027.

Why do group purchasing organizations and integrated delivery networks matter for healthtech sales?

About 97% of US hospitals hold a GPO affiliation, so GPO access can open doors across many facilities, but it rarely closes a deal by itself since facilities still decide whether to adopt. An IDN-level relationship carries more weight since one system-level decision opens several facilities at once, though it means surviving a system-wide security review instead of a lighter one.

About the author

Tara Minh

Senior Operations & Growth Strategist

Tara Minh is Senior Operations & Growth Strategist at Rework, helping B2B SaaS leaders scale without breaking their teams. With 8+ years in revenue operations and process optimization, Tara turns messy workflows into systems people actually follow. Readers get practical frameworks they can use to cut waste, align teams, and grow on purpose.

View full profile LinkedIn